Author

M. Arimont-Segura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. de Graaf· 2 shared R. Bosma· 2 shared R. Leurs· 2 shared A. Chevigne· 1 shared A. D. Windhorst· 1 shared A. Zarca· 1 shared B. A. Zarzycka· 1 shared B. Zarzycka· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. de Graaf

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintJul 17, 2023

Conformational dynamics underlying Atypical Chemokine Receptor 3 activation

O. Otun, C. Aljamous, E. Del Nero…·C. BECHARA

This study investigates the conformational dynamics of ACKR3 activation using HDX-MS and molecular dynamics simulations, revealing key structural changes and ligand binding mechanisms.

DOI 10.1101/2023.07.17.549382

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivJul 12, 2023

Pharmacological characterization and radiolabeling ofVUF15485, a high-affinity small-molecule agonist for theatypical chemokine receptor ACKR3

A. Zarca, I. Adlere, C. P. Viciano…·R. Leurs

This paper characterizes VUF15485, a high-affinity ACKR3 agonist, and reports its radiolabeling and binding properties.

DOI 10.1124/molpharm.123.000835

humanexperimental assay

𝕏 PostBluesky